A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

September 2, 2025

Study Completion Date

September 2, 2025

Conditions

Healthy

Interventions

DRUG

LY4064809

Administered orally

Trial Locations (1)

Pharmaron Clinical Pharmacology Center Inc, Baltimore

All Listed Sponsors

lead

Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company

INDUSTRY

NCT06991179 - A Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter